Estrogen receptor mutations in tamoxifen-resistant breast cancer.
暂无分享,去创建一个
G. T. Budd | R. Bukowski | G. Budd | P S Karnik | S Kulkarni | X P Liu | G T Budd | R M Bukowski | P. Karnik | S. Kulkarni | X. Liu | R. Bukowski | Pratima S Karnik | Sucheta Kulkarni | Xiao-Pu Liu
[1] W. Jonat,et al. The problem of nonresponding estrogen receptor‐positive patients with advanced breast cancer , 1980, Cancer.
[2] P. Chambon,et al. A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas , 1990, Nature.
[3] J. Deslypere,et al. Amino acid substitutions in the DNA-binding domain of the human androgen receptor are a frequent cause of receptor-binding positive androgen resistance. , 1992, Molecular endocrinology.
[4] W. McGuire,et al. Inhibition of estrogen receptor action by a naturally occurring variant in human breast tumors. , 1992, Cancer research.
[5] F. S. French,et al. Deletion of the steroid-binding domain of the human androgen receptor gene in one family with complete androgen insensitivity syndrome: evidence for further genetic heterogeneity in this syndrome. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[6] W. Isaacs,et al. Androgen receptor gene mutations in human prostate cancer. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[7] R. Cotton,et al. Detection of single base changes in nucleic acids. , 1989, The Biochemical journal.
[8] T. Sekiya,et al. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. , 1989, Genomics.
[9] P. Chambon,et al. Functional domains of the human estrogen receptor , 1987, Cell.
[10] P. Chambon,et al. The cloned human oestrogen receptor contains a mutation which alters its hormone binding properties. , 1989, The EMBO journal.
[11] B. O’Malley,et al. Point mutations in the human vitamin D receptor gene associated with hypocalcemic rickets. , 1988, Science.
[12] R. Simon,et al. Estrogen receptor status: an important variable in predicting response to endocrine therapy in metastatic breast cancer. , 1980, European journal of cancer.
[13] P. Chambon,et al. Characterization of the estrogen receptor in two antiestrogen-resistant cell lines, LY2 and T47D. , 1990, Cancer research.
[14] C. Benz,et al. Truncated forms of DNA-binding estrogen receptors in human breast cancer. , 1991, The Journal of clinical investigation.
[15] W. McGuire,et al. Estrogen receptor variants in clinical breast cancer. , 1991, Molecular endocrinology.
[16] J. Northrop,et al. Analysis of glucocorticoid unresponsive cell variants using a mouse glucocorticoid receptor complementary DNA clone. , 1986, The Journal of biological chemistry.
[17] K. Mullis,et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. , 1988, Science.
[18] W. McGuire,et al. Current status of estrogen and progesterone receptors in breast cancer , 1977, Cancer.
[19] J. Shine,et al. Sequence and expression of human estrogen receptor complementary DNA. , 1986, Science.